Drug Profile
HEP 689
Alternative Names: SB 235699Latest Information Update: 02 Aug 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Imidazoles; Small molecules
- Mechanism of Action Cytokine inhibitors; Protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Psoriasis